OECD report quantifies willingness to pay to avoid chemicals-related health effects
Chemical regulation increasingly requires governments to weigh compliance costs against harder-to-measure public health benefits. A new OECD report compiles internationally comparable estimates from more than 116,000 respondents in 28 countries to help quantify the value people place on avoiding non-fatal health effects linked to chemicals exposure.
Highlights
- OECD's new report quantifies willingness to pay to avoid 10 non-fatal chemicals-related health effects, informing environmental cost-benefit analysis.
- The report introduces a benefit-transfer methodology, enabling valuation extension to all 38 OECD countries and South Africa for practical policy comparison.
- Findings, based on responses from over 116,000 people in 28 countries, will be discussed at OECD Green Talks LIVE on 16 October 2026.
Report findings and policy use
As reported by OECD, the report "Economic Valuation of Chemicals-Related Health Effects: A Practical Guide to Quantifying Morbidity Effects in Environmental Cost-Benefit Analysis" provides valuation results intended for use in environmental cost-benefit analysis.It focuses on the economic benefits of reducing non-fatal health outcomes associated with chemicals exposure, an area where evidence on physical, emotional and social benefits is often limited. The publication maps willingness to pay to avoid or reduce the risk of experiencing 10 non-fatal health effects and examines factors that influence those valuations across countries.
The OECD also says the report introduces a benefit-transfer methodology designed to extend the valuations to all 38 OECD member countries and South Africa. That approach is intended to give policymakers a more practical tool for comparing the social benefits of stricter chemicals management with the costs those rules can impose on industry, consumers and governments.
Discussion planned for OECD Green Talks LIVE
OECD is set to discuss the findings at its next OECD Green Talks LIVE event on 16 October 2026 from 15:00 to 16:00 CEST. The session is due to examine how the estimates can support more effective chemicals management options and improve the treatment of health benefits in environmental policy appraisals.According to the OECD summary, the evidence base draws on responses from more than 116,000 people in 28 countries, providing a broad comparative dataset for regulators and analysts. After a presentation of the main findings, panellists are expected to discuss how the results can be applied in policy design and regulatory evaluation.
We previously reported on how tax authorities are evaluating artificial intelligence to strengthen transfer pricing oversight as cross-border structures become harder to monitor. Our earlier coverage highlighted potential AI use cases such as processing large datasets, spotting risk patterns, and supporting continuous monitoring, while also stressing that governance, traceability, and human oversight remain critical for accountable adoption.